Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. The company is headquartered in Hyderabad, Telangana and currently employs 26,944 full-time employees. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. The company works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Dr. Reddy's Laboratories Limited Informations sur les dividendes
Dr. Reddy's Laboratories Limited a un dividende annuel de 8.0041 par action, avec un rendement de 0.00%. Le dividende est payé annuellement et la dernière date d'ex-dividende était le Jul 25, 2025.
Rendement en dividend
Dividende annuel
Date ex-dividende
0.00%
$8.0041
Jul 25, 2025
Fréquence des paiements
Taux de distribution
Annuellement
0.00%
Historique des dividendes
Date ex-dividende
Montant en espèces
Date de registre
Date de paiement
Jul 25, 2025
$0.0915
Jul 10, 2025
Aug 6, 2025
Jul 30, 2024
$0.0952
Jul 15, 2024
Aug 12, 2024
Jul 28, 2023
$0.0965
Jul 10, 2023
Aug 11, 2023
Jul 7, 2023
$0.0975
Jul 10, 2023
Aug 1, 2023
Aug 1, 2022
$0.0757
Jul 11, 2022
Aug 12, 2022
Jul 30, 2021
$0.0673
Jul 9, 2021
Aug 11, 2021
Graphiques des dividendes
RDY Dividendes
RDY Croissance des dividendes (variation annuelle)